Molecular Determinants of Helicobacter pylori Pathogenicity and Antibiotic Resistance
A Special Issue of Biomolecules (ISSN 2218-273X) belonging to the section "Molecular Medicine".
Deadline for manuscript submissions: 30 November 2026 | Viewed by 1466
Editor
Interests: Helicobacter pylori; gastric cancer; virulence factors; epidemiology; human migration; antibiotics resistance; signal pathways; next generation sequencing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Helicobacter pylori remains one of the most important human pathogens associated with chronic gastritis, peptic ulcer disease, and gastric cancer. Although substantial progress has been made since its discovery, many of the molecular mechanisms underlying its pathogenicity, host adaptation, and clinical diversity remain incompletely understood. In parallel, the increasing prevalence of antibiotic resistance has become a major obstacle to successful eradication and effective gastric cancer prevention.
This Special Issue aims to highlight recent advances in the molecular basis of H. pylori pathogenicity and antibiotic resistance. We welcome original research articles and reviews addressing virulence factors, host–pathogen interactions, and resistance mechanisms, including studies using genomic, transcriptomic, epigenomic, proteomic, metabolomic, structural, and other molecular approaches. We particularly encourage contributions that connect molecular findings with clinical outcomes and disease risk.
Prof. Dr. Yoshio Yamaoka
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Helicobacter pylori
- pathogenicity
- antibiotic resistance
- virulence factors
- host–pathogen interaction
- gastric cancer
- genomics
- transcriptomics
- proteomics
- metabolomics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
